comparemela.com

Latest Breaking News On - Clinical research at pfizer inc - Page 1 : comparemela.com

IDEAYA Biosciences Appoints Darrin M Beaupre, M D , Ph D , as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and.

Darrinm beaupreYujiros hataHead of researchH lee moffitt cancer centerMd anderson cancer centerHead of early developmentExchange commissionHead of early oncology developmentBiosciences incResearch instituteClinical research at pfizer incUniversity of miamiDevelopment in oncologyClinical research at pfizerFormer senior vice presidentEarly oncology development

Imugene Ltd bolsters executive management team with Dr Steven Cha appointed chief medical officer

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed Dr Steven Cha as its chief medical officer (CMO) and a member of its executive management team. Dr Cha will.

Stanford universityUnited statesSan diegoLeslie chongSteven chaUniversity of californiaImugene ltdClinical research at pfizer incTufts university school of medicineEarly oncology developmentClinical researchPfizer incMetastatic breast cancer franchiseBispecifict cell engagerCell biologyTufts university school

Imugene Ltd bolsters executive management team with Dr Steven Cha appointed chief medical officer

Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed Dr Steven Cha as its chief medical officer (CMO) and a member of its executive management team. Dr Cha will.

Stanford universityUnited statesSan diegoLeslie chongSteven chaUniversity of californiaImugene ltdClinical research at pfizer incTufts university school of medicineEarly oncology developmentClinical researchPfizer incMetastatic breast cancer franchiseBispecifict cell engagerCell biologyTufts university school

vimarsana © 2020. All Rights Reserved.